SAR values for the localizer sequences were quite high (even beyond the US Food and Drug Administration safety limits). This was not expected, and was most likely due to a calculation error or a bug in the SAR value calculation and reporting program, rather than actual high SAR values in the scans.
Additionally, we noticed some inconsistencies in the relationship between reported SAR values and patient body weight for the 3-T systems from one MRI vendor. As shown in Fig. 2(a) , the SAR values were negatively correlated with patient body weight, whereas in theory they should be positively correlated with body weight (as shown in Fig. 2(b) for the 1.5-T scanners from the same vendor). Our survey results cast doubt on the accuracy and reliability of reported SAR values, and indicate that SAR reporting should be standardized to ensure consistency and reliability in reported SAR values, which are becoming more important for clinical decisions involving the use of MRI in patients with implanted devices. We hope to raise awareness of this issue among clinical users who currently completely rely on these reported SAR values. We also hope that this will be the first step to bring the medical physics community together to demand openness and standardization from MRI manufacturers in the calculation of SAR values, and that this will ultimately lead to some kind of independent validation of SAR values, as is currently done for radiation doses in CT studies.
